Lama3 mutations correlated with tumour grade (p = 0.00233), total immune infiltrate (CD45+, p = 0.029824), exofitic tumour growth (p = 0.05172) and tumour invasiveness (p = 0.02748) (Fig. 5e, Supplementary Data 6). The gene discussed is PTPRC; the disease is neoplasm.